Fintel reports that on September 24, 2024, Baird initiated coverage of ResMed Inc. - Depositary Receipt () (ASX:RMD) with a Outperform recommendation.
Analyst Price Forecast Suggests 22.93% Upside
As of August 26, 2024, the average one-year price target for ResMed Inc. - Depositary Receipt () is $34.37/share. The forecasts range from a low of $29.85 to a high of $38.94. The average price target represents an increase of 22.93% from its latest reported closing price of $27.96 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for ResMed Inc. - Depositary Receipt () is 4,507MM, a decrease of 3.81%. The projected annual non-GAAP EPS is 7.36.
What is the Fund Sentiment?
There are 9 funds or institutions reporting positions in ResMed Inc. - Depositary Receipt (). This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to RMD is 2.08%, an increase of 12.15%. Total shares owned by institutions increased in the last three months by 170.12% to 5,974K shares.
What are Other Shareholders Doing?
Bernstein Fund Inc - International Strategic Equities Portfolio SCB Class holds 4,994K shares. In its prior filing, the firm reported owning 1,224K shares , representing an increase of 75.50%. The firm increased its portfolio allocation in RMD by 301.34% over the last quarter.
AB VARIABLE PRODUCTS SERIES FUND, INC. - AB International Value Portfolio holds 306K shares. In its prior filing, the firm reported owning 320K shares , representing a decrease of 4.44%. The firm decreased its portfolio allocation in RMD by 1.20% over the last quarter.
Aberdeen Australia Equity Fund holds 213K shares. No change in the last quarter.
EDOC - Global X Telemedicine & Digital Health ETF holds 157K shares. In its prior filing, the firm reported owning 174K shares , representing a decrease of 10.72%. The firm increased its portfolio allocation in RMD by 0.87% over the last quarter.
ABIAX - AB International Value Fund holds 107K shares. In its prior filing, the firm reported owning 99K shares , representing an increase of 7.93%. The firm increased its portfolio allocation in RMD by 43.72% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
